GOSSAMER BIO, INC. (GOSS) Operating income 2017–2025
GOSSAMER BIO, INC. (GOSS) annual operating income history from SEC filings — each fiscal year as reported.
-$170.7MFY2025 · since FY2017: -$6.7M → -$170.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$170.7M | -184.9% |
| FY2024 | -$59.9M | +67.4% |
| FY2023 | -$183.8M | +15.9% |
| FY2022 | -$218.6M | -1.1% |
| FY2021 | -$216.1M | +7.6% |
| FY2020 | -$234.0M | -25.7% |
| FY2019 | -$186.1M | -24.9% |
| FY2018 | -$149.0M | -2139.5% |
| FY2017 | -$6.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice